JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110139200 on February 12, 2002

J. Biol. Chem., Vol. 277, Issue 18, 15801-15806, May 3, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/18/15801    most recent
M110139200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thrower, E. C.
Right arrow Articles by Ehrlich, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thrower, E. C.
Right arrow Articles by Ehrlich, B. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Activation of the Inositol 1,4,5-Trisphosphate Receptor by the Calcium Storage Protein Chromogranin A*

Edwin C. ThrowerDagger §, Hee Yun Park, Seung Ho So, Seung Hyun Yoo, and Barbara E. EhrlichDagger

From the Dagger  Departments of Pharmacology and Cellular & Molecular Physiology, Yale University, New Haven, Connecticut 06520 and  National Creative Research Initiative Center for Secretory Granule Research, Korea Advanced Institute of Science and Technology, Dae Jeon 305-701, Korea

Received for publication, October 22, 2001, and in revised form, February 6, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Secretory granules of neuroendocrine cells are inositol 1,4,5-trisphosphate (InsP3)-sensitive Ca2+ stores in which the Ca2+ storage protein, chromogranin A (CGA), couples with InsP3-gated Ca2+ channels (InsP3R) located in the granule membrane. The functional aspect of this coupling has been investigated via release studies and planar lipid bilayer experiments in the presence and absence of CGA. CGA drastically increased the release activity of the InsP3R by increasing the channel open probability by 9-fold and the mean open time by 12-fold. Our results show that CGA-coupled InsP3Rs are more sensitive to activation than uncoupled receptors. This modulation of InsP3R channel activity by CGA appears to be an essential component in the control of intracellular Ca2+ concentration by secretory granules and may regulate the rate of vesicle fusion and exocytosis.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

CGA1 is a member of the granin protein family and is stored in high concentrations in the large dense core secretory granules of most endocrine and neuroendocrine cells as well as in many nerve cells in the periphery and brain (1, 2). CGA, the first member of the granin family to be discovered (3-5), has a wide variety of functions, both extracellular and intracellular.

As one of its extracellular functions, CGA acts as a prohormone, a protein that contains numerous sites for proteolytic processing. Following secretion, extracellular proteases cleave CGA, generating several peptide fragments with biological activity, including pancreastatin (6, 7), vasostatins I and II (8-10), parastatin (11), catestatin (12), and chromacin (13). In healthy individuals, CGA and its peptide fragments are present in the circulatory system in low nanomolar quantities. However, in patients suffering from pheochromocytoma and other neuroendocrine tumors, concentrations are significantly higher (14). Elevated plasma levels of CGA are associated with a number of pathological conditions making the protein an ideal marker not only for neuroendocrine tumors but also for chronic heart failure and brain disorders such as Parkinson's and Alzheimer's diseases (15).

Among its intracellular roles, CGA has been shown to interact with ATP, catecholamines, and Ca2+ (16, 17), to acidify the intravesicular medium and to sort proteins for the regulated secretory pathway via a range of protein-protein interactions (15). These sorting functions include aggregation with chromogranin B, complexing with dopamine beta -hydroxylase, t-plasminogen activator, and binding secretory granule membrane constituents such as the InsP3R (15).

In recent years, secretory granules of neuroendocrine cells have been identified as inositol (1,4,5)-trisphosphate (InsP3)-sensitive Ca2+ stores (18-20). In the granules CGA forms a tetramer and appears to bind four molecules of the intraluminal loop of the InsP3R at the intravesicular pH 5.5 (21-23). In vitro studies show that purified InsP3R interact directly with CGA at this pH and dissociate from it at pH 7.5, a pH encountered when exocytosis occurs (24). Co-transfection of InsP3R and CGA into COS-7 cells followed by co-immunoprecipitation demonstrates that these two proteins form a complex in vivo (24).

We have investigated the functional aspect of this coupling via InsP3-mediated Ca2+ release studies using InsP3R-reconstituted liposomes in the presence and absence of CGA. We have further characterized the molecular basis of this phenomenon at the single channel level using planar lipid bilayer studies. In the presence of CGA the open probability and mean open time of the InsP3R channel increases significantly. Hence, modulation of InsP3R channel activity by CGA appears to be an essential component in the control of intracellular Ca2+ concentration in secretory granules.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Purification of the InsP3 Receptor

For Flux Studies-- The type I InsP3 receptor was isolated from bovine cerebella as described previously (25). Briefly, bovine cerebella were mixed with 3 volumes of buffer I (50 mM Tris-HCl, pH 7.4, 0.32 M sucrose, 1 mM EDTA, 1 mM beta -mercaptoethanol, 0.1 mM PMSF, 10 µM leupeptin, 10 µM pepstatin), homogenized, and centrifuged at 2000 × g for 10 min at 4 °C. The supernatants were re-centrifuged at 105,000 × g for 1 h to precipitate the membrane pellet, which was resuspended in buffer II (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM beta -mercaptoethanol, 0.1 mM PMSF, 10 µM leupeptin, 10 µM pepstatin) containing 1% Triton X-100, stirred for 1 h, and then centrifuged at 32,000 × g for 1 h at 4 °C. The resulting supernatant was mixed with an equal volume of buffer III (20 mM Tris-HCl, pH 7.5, 0.1 M NaCl, 1% Triton X-100, 1 mM beta -mercaptoethanol, 0.1 mM PMSF, 10 µM leupeptin, 10 µM pepstatin), and applied to an InsP3R antibody-coupled immunoaffinity column (0.35 × 1 cm) equilibrated with 20 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM CaCl2. The protein-loaded column was washed with 20 bed volumes of this buffer, and the InsP3R was eluted by 10 ml of elution buffer (0.1 M glycine, pH 2.8, 0.2% Triton X-100, 0.5 M NaCl, 1 mM beta -mercaptoethanol, 0.1 mM PMSF, 10 µM leupeptin, 10 µM pepstatin). The eluate was immediately neutralized by adding 1 M Tris-HCl, pH 9.5, and mixed with an equal volume of buffer IV (50 mM Tris-HCl, pH 8.0, 0.2% Triton X-100, 0.5 M NaCl, 1 mM beta -mercaptoethanol); it was then applied to a benzamidine-Sepharose column equilibrated with Buffer V (20 mM HEPES, pH 7.5, 100 mM NaCl, 1 M KCl, and 3 M urea). InsP3R containing flow-through was collected and stored at -70 °C. until use.

For Bilayer Experiments-- The type I InsP3 receptor was solubilized in 1% CHAPS and purified from mouse cerebellum using heparin affinity and concanavalin A-Sepharose column chromatography as described previously (26). The purified InsP3R was then incorporated into liposomes by adding 15 µg of purified protein to 1 ml of liposome solution (consisting of phosphatidylcholine in bilayer buffer), mixing, and then incubating on ice for 10 min.

Flux Studies

InsP3 Dose Response for InsP3R-- InsP3R proteoliposomes were formed as described previously (25). Some of these proteoliposomes had CGA encapsulated in them, and the remainder was used for control experiments. Ca2+ efflux from the proteoliposomes was measured by observing changes in indo-1 fluorescence. Fluorometric measurements were carried out at 35 °C using a Shimadzu RF-5301 PC spectrofluorometer equipped with a temperature-controlled cuvette holder. Fluorescence intensity was measured at the emission wavelength of 393 nm (excitation of 355 nm) with 10 nm of excitation band slit width and 10 nm of emission band slit width. For the kinetic analysis of InsP3-induced Ca2+ release, the data were acquired every 20 ms after each addition of the indicated InsP3 concentration to 0.5 ml of the proteoliposome solution. The fluorescent intensities of indo-1 were calibrated to free Ca2+ concentrations using a Ca2+-EGTA buffering system (27).

InsP3 dose-dependent Ca2+ release was also measured by the intensity of indo-1 fluorescence after each InsP3 addition and was compared with the fluorescence intensity after the addition of Triton X-100 instead of InsP3. In these experiments, 10 µM indo-1 was used, which is a high enough concentration to buffer released Ca2+, thus precluding the possibility of Ca2+ regulation of the InsP3-induced release.

Bilayer Experiments-- Planar lipid bilayers were formed by painting a solution of phosphatidylethanolamine/phosphatidylserine (3:1; 30 mg/ml in decane) across a 100 µm aperture in a Teflon sheet bisecting a Lucite chamber. The hole was pre-painted with phosphatidylcholine/phosphatidylserine (3:1) prior to membrane formation. The two compartments are defined as cis (corresponding to the cytosol) and trans (corresponding to the lumen of the ER).

The cis (cystolic) compartment consisted of 250 mM HEPES, Tris, pH 7.35, 0.5 mM EGTA ([Ca2+]free = 200 nM), ATP 0.5 mM, and ruthenium red 2 µM.

The trans (luminal) compartment consisted of 250 mM HEPES, adjusted to pH 5.5 (as purified InsP3R was used in these experiments, the pH could be changed using 70 mM HCl), and 53 mM Ba(OH)2. Single channel currents were amplified using a bilayer clamp amplifier (Warner Instruments) and recorded on digital tape. Data was filtered with an eight-pole Bessel filter to 500 Hz, digitized to 2 kHz, transferred to a personal computer, and analyzed using the pClamp 6.0 (Axon Instruments) software package.

InsP3R proteoliposomes were added to the cis compartment and mixed followed by the addition of 2 µM InsP3 to the same compartment. Upon InsP3R activation, single channel activity was recorded. CGA (1 µg) was added to the trans compartment and mixed. InsP3R single channel activity was recorded. The pH inside the trans compartment was changed by adding Tris (final concentration 110 mM) to pH 7.5 (to dissociate CGA from InsP3R), and InsP3R single channel activity was recorded.

These experiments were repeated (i) in the presence of increasing doses of InsP3 (over the range of 0.2-2 µM) to the cis compartment and (ii) at a fixed InsP3 concentration of 2 µM in the presence of increasing free Ca2+ concentrations (over the range of 0.01-1 µM) to the cis compartment. Both steps i and ii were carried out in the presence and absence of 1 µg of CGA in the trans compartment, and InsP3R single channel activity was recorded.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effect of CGA on InsP3-mediated Ca2+ Release-- The effect of CGA on InsP3 dose response for type I InsP3R from bovine cerebella was investigated initially using Ca2+ release studies. InsP3-induced Ca2+ release from InsP3R-reconstituted liposomes was monitored both in the presence and absence of CGA (Fig. 1). InsP3-induced Ca2+ efflux through the proteoliposomes (300 µM Ca2+ inside) was determined by the change of indo-1 fluorescence at 393 nm. The total amount of Ca2+ in the liposomes was determined by adding 1% Triton X-100, and this was the value set at 100%. Given this information, the total amount of InsP3-releasable Ca2+ was estimated to be 60%. When CGA was present inside the vesicle at pH 5.5, the pH value at which CGA associates with the InsP3R, InsP3-induced Ca2+ release was significantly enhanced (see Fig. 1a). A Kapp value for InsP3 of 0.2 µM was obtained. When the pH was maintained at 7.5, however, the fluorescent changes seen at each InsP3 dose more closely resembled those seen in the absence of CGA at pH 5.5 (Kapp values for InsP3 of 0.8 and 0.9 µM, respectively), further supporting the pH dependence of the InsP3R/CGA interaction. The presence of CGA at pH 5.5 markedly increased the apparent affinity of the receptor for InsP3 when compared with the Ca2+ release obtained in the absence of CGA. This result complements the effect of CGA on InsP3 binding to its receptor (25). Even at InsP3 concentrations lower than those published previously (starting at 0.05 µM) (25), an increase in apparent affinity for InsP3 was seen (Fig. 1b).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of CGA on InsP3-induced Ca2+ release from InsP3R-reconstituted liposomes. a, InsP3-induced Ca2+ efflux through the proteoliposomes (300 µM Ca2+ inside) was determined by the fluorescence change of indo-1 at 393 nm after a series of incremental additions of InsP3 (4.0 µM final) to the proteoliposome solution. The intraliposomal pH was pH 5.5 unless stated otherwise. InsP3-induced Ca2+ release was also measured in the presence of encapsulated CGA at intraliposomal pH of 5.5 and 7.5. b, the amount of released Ca2+ measured after a series of incremental additions of InsP3 (4.0 µM final) to the proteoliposome solution containing 1 µM indo-1 at 35 °C. InsP3-induced fluorescent changes were compared with that obtained by the addition of Triton X-100 (this value was set at 100%).

Effect of CGA upon InsP3R Channel Activity-- The enhancement of Ca2+ release from InsP3R-reconstituted liposomes as a result of the pH-dependent interaction of CGA with InsP3R, illustrates a functional phenomenon associated with this coupling. To further define the actual mechanism of action, we investigated these effects at the single channel level using InsP3 R incorporated into planar lipid bilayers.

Under control conditions, in the absence of luminal CGA and in the presence of cytosolic free Ca2+ (300 nM) and InsP3 (2 µM), mouse InsP3R type I, single channel activity was observed (see Fig. 2a, trace i). Single channel currents of ~2 pA were seen, and the presence of a pH gradient between the trans and cis compartments (pH 5.5:pH 7.35) did not affect channel activity. Two populations of mean open times were seen with values of 0.864 ± 0.039 and 8.84 ± 0.014 ms (Fig. 3a). The data set is further expanded (Fig. 3b) to emphasize the complete population of longer open times. The open probability (Po) was 4.0 ± 1.0% (S.E.) (n = 4).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   a, single channel activity in the presence of InsP3R. Trace i, InsP3R single channels activated by 2 µM InsP3 (added to the cis compartment). Openings are defined as downward deflections from the base line. Trace ii, conditions are same as for trace i, except CGA (1 µg) was added to the trans compartment and mixed. The pH of the trans compartment was pH 5.5. Trace iii, The pH inside the trans compartment was changed by the addition of Tris (final concentration 110 mM) to pH 7.5 (to dissociate CGA from IP3R). b, effect of heparin, a charged macromolecule, on InsP3R function. Top trace, InsP3R single channels activated by 2 µM InsP3 (added to the cis compartment). Openings are defined as downward deflections from the base line. Lower trace, heparin (1 µg) was added to the trans compartment and mixed. The pH of the trans compartment was pH 5.5. As CGA is a highly charged protein, these control experiments exclude the possibility that any charged macromolecule could be responsible for the effects observed in this study.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Mean open times for InsP3R in the presence and absence of CGA. a, mean open times for InsP3R in the absence of CGA. Two populations of open times are observed with values of 0.864 ± 0.039 and 8.84 ± 0.014 ms. b, an expanded section with a fit to the data. This experiment is typical of four similar but separate experiments. c, mean open times for InsP3R in the presence of CGA. Again, two populations of open times are observed with values of 2.61 ± 0.024 and 103.5 ± 0.003 ms, but now the number of longer openings has increased, and the mean open time is greater. d, an expanded section with a fit to the data. The increase in the number of longer open times is illustrated clearly. This experiment is typical of four similar but separate experiments. e, mean open times for InsP3R following dissociation of CGA by pH change (pH 5.5 to pH 7.5). Two populations of open times are observed with values of 1.05 ± 0.014 and 7.19 ± 0.013 ms, and the open times have returned to control levels. f, an expanded section with a fit to the data (n = 4).

Less than 1 min after the addition of 1 µg of CGA to the trans compartment, a dramatic change in channel activity was observed (Fig. 2a, trace ii). The magnitude of the single channel current remained unaltered; however, significant differences were apparent in mean open times and Po. Two populations of mean open time were evident, as before, but were greatly increased over control values (Fig. 3c). Values of 2.61 ± 0.024 and 103.5 ± 0.003 ms were obtained, illustrating an approximate 3-fold and 12-fold increase of open time in each respective population. This is displayed even more clearly when the scale from Fig. 3c is expanded to focus on the population of longer open times (Fig. 3d). Furthermore, a large increase in Po over control levels was seen with a value of 33.0 ± 8.5% (S.E.) (n = 4).

By changing the pH of the trans compartment to 7.5, a condition known to cause dissociation of CGA from InsP3R, channel activity essentially reverted to control levels (Fig. 2a, trace iii). The two populations of mean open time were reduced to 1.05 ± 0.014 and 7.19 ± 0.013 ms (n = 4, Fig. 3e, and compare with Fig. 3a), and the Po was reduced to 3.0 ± 1.6% (S.E.), a value close to that seen for the control. The addition of heparin, an InsP3R-specific antagonist, to the cis compartment inhibited channel activity completely.

A similar study was carried out using microsomes from mouse cerebellum to see whether the effects of CGA would still be seen in native tissue the same as in purified protein. These experiments were complicated by the fact that HCl was present in the trans compartment, a condition necessary for maintaining the pH at 5.5. Thus chloride channels present in the microsomes were activated, making the analysis difficult. Nonetheless, under comparable control conditions to those described for the purified receptor, the open probability was 8%; and upon addition of CGA to the trans compartment this increased to 52%. Altering the pH of the trans compartment lowered the open probability to ~1%.

The addition of CGA to the trans compartment in the absence of InsP3R had no effect upon the bilayer itself, and CGA did not potentiate any InsP3R channel activity in the absence of cytosolic InsP3. Furthermore, the addition of 1 µg of CGA to the cis compartment in the presence of InsP3R and InsP3 did not affect channel activity.

As CGA is a highly charged protein, control experiments were carried out to exclude the possibility that any charged macromolecule could be responsible for the effects observed in this study. Heparin is one such charged macromolecule and is known for its inhibitory effects on the InsP3R when exposed to the cytosolic face of the receptor, although it is not known to bind to its luminal face. The addition of 1 µg of heparin to the trans compartment (see Fig. 2b) did not alter channel open probability (5% for the control compared with 4.4% in the presence of luminal heparin), indicating that CGA does have a specific modulatory effect on InsP3Rs.

Effect of CGA on InsP3 Dose Response for InsP3R-- Single channel activity as a function of InsP3 concentration, both in the presence and absence of CGA, was characterized next (Fig. 4, a and b). Over a range of InsP3 concentrations starting at 0.2 µM, the open probability was greater in the presence of CGA, with a 14-fold increase observed at 2 µM InsP3. When the pH of the trans compartment was changed to 7.5, the Po was reduced to that seen in the control experiments. The results obtained from the single channel experiments concur with those seen in the Ca2+ release studies (see Fig. 1) in that, at each InsP3 concentration and in the presence of CGA, a significant increase in Po is concomitant to an increased amount of released Ca2+.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of CGA on InsP3 dose response for InsP3R. Bilayer experiments were repeated, same conditions as before, except over a range of InsP3 concentrations. a, InsP3 R single channels activated by 0.2-2 µM InsP3 (added to the cis compartment) are shown. The InsP3 concentration used is shown in the figure next to the relevant traces. Openings are defined as downward deflections from the base line. The channel traces shown on the left are in the absence of CGA. Channel traces shown on the right are in the presence of CGA (1 µg) in the trans compartment maintained at pH 5.5. b, at each InsP3 concentration the open probability was measured in the presence () and absence (black-diamond ) of CGA. CGA significantly enhances Po by at least 10-fold. The data set shown is typical of four similar experiments.

Effect of CGA on Ca2+ Dependence for InsP3R-- The Ca2+-dependence of the InsP3R was investigated in the absence and presence of CGA (Fig. 5, a and b) at a fixed InsP3 concentration of 2 µM and over a Ca2+ concentration range of 0.01-1.0 µM. As the Ca2+ concentration in the cis compartment increased successively from 0.01 to 0.3 µM, the Po increased, reaching a maximum value of 4% at 1 µM Ca2+ (pCa 6) in the absence of CGA (Fig. 5b). At Ca2+ concentrations higher than 0.3 µM (pCa 6.5), no inhibition was seen (see Fig. 5b, expanded section). This lack of inhibition by free Ca2+ has been observed previously for purified receptor (28, 29) and contrasts to the inhibition seen with microsomes (30). Repetition of this experiment, with the addition of CGA to the trans compartment, produced dramatic increases in channel activity (Fig. 5a). At a Ca2+ concentration of 0.01 µM (pCa 8) the Po is effectively zero in the absence of CGA, in contrast to the Po observed when CGA is present, which expressed as a percentage of total open probability is 34%. Furthermore, the Po effectively remains at this level irrespective despite increasing Ca2+ concentrations, and again no inhibition by Ca2+ is seen. The activating phase of the Ca2+ dependence seen in the absence of CGA is not apparent in its presence. The channel has reached maximal open probability at pCa 8. Thus, the lack of dependence on Ca2+ for activation in the presence of CGA and 2 µM InsP3 is clearly illustrated.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of CGA on Ca2+ dependence for InsP3R. Bilayer experiments were repeated under the same conditions as described under "Materials and Methods" except over a range of cytosolic Ca2+ concentrations (0.01-10 µM). a, InsP3R single channels activated by 2 µM InsP3 and in the presence of different Ca2+ concentrations (added to the cis compartment) are shown. The free Ca2+ concentration used is shown next to the relevant traces. Openings are defined as downward deflections from the base line. The channel traces shown on the left are in the absence of CGA. Channel traces shown on the right are in the presence of CGA (1 µg) in the trans compartment. b, at each Ca2+ concentration the open probability was measured in the presence () and absence (black-diamond ) of CGA. The Ca2+ dependence in the absence of CGA is shown (expanded section is shown to emphasize that purified InsP3Rs are not inhibited at higher cytosolic Ca2+ concentrations). Again, CGA significantly enhances Po. At the lowest Ca2+ concentration the Po of the channel is already at 34%, with no indication of an activation phase. The data set shown is typical of four similar experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Secretory granules of endocrine and neuroendocrine cells have been shown to serve as InsP3-sensitive intracellular Ca2+ stores (18, 31), and additional evidence from goblet cells has demonstrated their direct participation in the control of cytoplasmic Ca2+ (20). Chromogranins are Ca2+ storage proteins that are found in secretory granules in millimolar concentrations (1-2 mM) (1, 32), and CGA binds 32 mol of Ca2+/mol with a dissociation constant of 2.7 mM at pH 7.5 and 55 mol of Ca2+/mol with a dissociation constant of 4 mM at pH 5.5 (33). Given the high capacity Ca2+ binding of CGA, most of the 40 mM intravesicular Ca2+ remains bound, thus yielding a total free Ca2+ concentration of ~24 µM inside the granules (34). As secretory granules occupy about 10% of the total cell volume (at least in bovine chromaffin cells) (32) and have a high storage capacity for Ca2+, they may play an important role in governing intracellular Ca2+ dynamics.

This hypothesis is further supported by the discovery that chromogranins A and B interact directly with type I InsP3Rs located on the secretory granule membrane (24) and that this coupling is functional, at least in terms of CGA (25). The present results obtained from our bilayer studies reemphasize the functional importance of the interaction and provide the first mechanistic insight at the level of a single InsP3R. The effects of CGA on InsP3R channel activity, at the intravesicular pH of 5.5 (the pH at which the coupling occurs), are very profound. The increase in both mean open time and open probability (Fig. 3) demonstrates clearly that CGA causes the channel to open more frequently and, once open, to stay open for longer times, which when translated to the cellular level, implies a greater release of Ca2+. When the intravesicular pH is altered to 7.5, the effects of CGA are seen to dissipate almost instantly (Fig. 2, trace iii, and Fig. 3, e and f) and resemble more closely those seen at pH 5.5 in the absence of CGA. The InsP3 concentration dependence both in bilayer studies and flux studies carried out at comparable concentrations complement one another. At the single channel level the InsP3R is seen to have a greater chance of opening when CGA is present, and in the flux studies, the apparent affinity for InsP3 is greater. Again, a change in pH to 7.5 causes the effect to revert to control levels. As for Ca2+ dependence, the InsP3R is already active at maximal levels when CGA and InsP3 are present even when the level of cytosolic free Ca2+ is only 10 nM (Fig. 5). The data shown in Figs. 4 and 5 indicate that in the presence of coupled CGA and a sufficient concentration of InsP3 (2 µM), the characteristic effects of cytosolic Ca2+ on the InsP3R channel disappear. It appears that the conformation of the InsP3R is in such a state in the CGA-coupled condition, that high InsP3 dictates the channel activity regardless of the presence of Ca2+.

How do these results relate to the physiological situation? In the presence of CGA at intravesicular pH 5.5, the InsP3R is primed to respond to low levels of InsP3. Hence, when a secretory granule reaches the surface of the cell and docks with the inner surface of the plasma membrane, it is fully loaded with Ca2+ and sensitized for release. Generation of InsP3, even in small quantities, will cause a large elevation in local Ca2+ concentration (values as high as 100 µM have been seen immediately prior to exocytosis) (23), initiating secretory processes. During exocytosis, the vesicle contents are exposed to the extracellular pH of 7.4, thus causing dissociation of CGA from the InsP3R resulting in altered channel properties and hence Ca2+ release. Following these events, vesicular contents dissociate from the vesicle membrane, with secretory cargo moving to the extracellular space and then into the bloodstream.

The chromogranins, particularly CGA, appear to play a role in intracellular Ca2+ dynamics and secretion, which also has significant implications to human disease. For example, patients suffering from pheochromocytoma and other neuroendocrine tumors have significantly higher concentrations of CGA measured in the plasma (14, 15). This high plasma CGA indicates that high levels must have been stored in order to be released. Individual cells contain increased CGA, and there are more CGA-containing cells. In various cholestatic liver diseases, a striking increase is seen in the number of bile ductules (35). These reactive bile ductules differ from their normal counterparts in that they display neuroendocrine features, in particular the expression of CGA. Hence, the presence of elevated CGA can lead to abnormal Ca2+ release within these cells, thus activating specific metabolic mechanisms in the cell, which leads to unnecessary growth. The increased release of neuroendocrine substances, including CGA, may also play an autocrine or paracrine regulatory role in ductular metaplasia of hepatocytes or bile ductule growth. Thus, although the role of CGA in disease is largely attributed to extracellular CGA and its derivatives, a contribution may arise also from intragranular CGA with respect to its effects on intracellular Ca2+ release and exocytosis.

In conclusion, our present work is the first electrophysiological study detailing the very important physiological phenomenon arising from the interaction between CGA, a Ca2+ storage protein, and an intracellular Ca2+ release channel, InsP3R. We have shown that there is an order of magnitude increase in the open probability and open time of the InsP3-gated Ca2+ channel. These effects of the interaction of CGA and InsP3R have implications for exocytosis and neuroendocrine cell function in disease.

    FOOTNOTES

* This work was supported by Grant GM63496 from the National Institutes of Health, an American Heart Association fellowship, Heritage Affiliate (to E. C. T.), and the Creative Research Initiatives Program of the Ministry of Science and Technology, Korea.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Pharmacology, Yale University, 333 Cedar St., New Haven, CT 06520-8066. Tel.: 203-737-1158; Fax: 203-785-7670; E-mail: edwin.thrower@yale.edu.

Published, JBC Papers in Press, February 12, 2002, DOI 10.1074/jbc.M110139200

    ABBREVIATIONS

The abbreviations used are: CGA , chromogranin A; InsP3, inositol 1,4,5-trisphosphate; InsP3R, InsP3R receptor; PMSF, phenylmethylsulfonyl fluoride; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Simon, J. P., and Aunis, D. (1989) Biochem. J. 262, 1-13[Medline] [Order article via Infotrieve]
2. Winkler, H., and Fischer-Colbrie, R. (1992) Neuroscience 49, 497-528[CrossRef][Medline] [Order article via Infotrieve]
3. Helle, K. B. (1966) Mol. Pharmacol. 2, 298-310[Abstract/Free Full Text]
4. Blaschko, H., Comline, R. S., Schneider, F. H., Silver, M., and Smith, A. D. (1967) Nature 215, 58-59[CrossRef][Medline] [Order article via Infotrieve]
5. Smith, A. D., and Winkler, H. (1967) Biochem. J. 103, 483-492[Medline] [Order article via Infotrieve]
6. Tatemoto, K., Efendic, S., Mutt, V., Makk, G., Feistner, G. J., and Barchas, J. D. (1986) Nature 324, 476-478[CrossRef][Medline] [Order article via Infotrieve]
7. Lewis, J. J., Zdon, M. J., Adrian, T. E., and Modlin, I. M. (1988) Surgery 104, 1031-1036[Medline] [Order article via Infotrieve]
8. Drees, B. M., Rouse, J., Johnson, J., and Hamilton, J. W. (1991) Endocrinology 129, 3381-3387[Abstract]
9. Aardal, S., Helle, K. B., Elsayed, S., Reed, R. K., and Serck-Hanssen, G. (1993) J. Neuroendocrinol. 5, 405-412[CrossRef][Medline] [Order article via Infotrieve]
10. Helle, K. B., Serck-Hanssen, G., and Aardal, S. (1993) Neurochem. Int. 22, 353-360[CrossRef][Medline] [Order article via Infotrieve]
11. Fasciotto, B. H., Trauss, C. A., Greeley, G. H., and Cohn, D. V. (1993) Endocrinology 133, 461-466[Abstract]
12. Mahata, S. K., O'Connor, D. T., Mahata, M., Yoo, S. H., Taupenot, L., Wu, H., Gill, B. M., and Parmer, R. J. (1997) J. Clin. Invest. 100, 1623-1633[Medline] [Order article via Infotrieve]
13. Strub, J. M., Sorokine, O., Van Dorsselaer, A., Aunis, D., and Metz-Boutigue, M. H. (1997) J. Biol. Chem. 272, 11928-11936[Abstract/Free Full Text]
14. Aardal, S., Aardal, N. P., Larsen, T. H., Angeletti, R. H., Stridsberg, M., Taupenot, L., Aunis, D., and Helle, K. B. (1996) Scand. J. Clin Lab. Invest. 56, 511-523[Medline] [Order article via Infotrieve]
15. Helle, K. B., and Aunis, D. (2000) Adv. Exp. Med. Biol. 482, 389-397[Medline] [Order article via Infotrieve]
16. Kopell, W. N., and Westhead, E. W. (1982) J. Biol. Chem. 257, 5707-5710[Abstract/Free Full Text]
17. Daniels, A. J., Williams, R. J., and Wright, P. E. (1978) Neuroscience 3, 573-585[CrossRef][Medline] [Order article via Infotrieve]
18. Yoo, S. H., and Albanesi, J. P. (1990) J. Biol. Chem. 265, 13446-13448[Abstract/Free Full Text]
19. Gerasimenko, O. V., Gerasimenko, J. V., Belan, P. V., and Petersen, O. H. (1996) Cell 84, 473-480[CrossRef][Medline] [Order article via Infotrieve]
20. Nguyen, T., Chin, W. C., and Verdugo, P. (1998) Nature 395, 908-912[CrossRef][Medline] [Order article via Infotrieve]
21. Yoo, S. H., and Lewis, M. S. (1992) J. Biol. Chem. 267, 11236-11241[Abstract/Free Full Text]
22. Thiele, C., and Huttner, W. B. (1998) J. Biol. Chem. 273, 1223-1231[Abstract/Free Full Text]
23. Yoo, S. H. (2000) Trends Neurosci. 23, 424-428[CrossRef][Medline] [Order article via Infotrieve]
24. Yoo, S. H., So, S. H., Kweon, H. S., Lee, J. S., Kang, M. K., and Jeon, C. J. (2000) J. Biol. Chem. 275, 12553-12559[Abstract/Free Full Text]
25. Yoo, S. H., and Jeon, C. J. (2000) J. Biol. Chem. 275, 15067-15073[Abstract/Free Full Text]
26. Thrower, E. C., Mobasheri, H., Dargan, S., Marius, P., Lea, E. J., and Dawson, A. P. (2000) J. Biol. Chem. 275, 36049-36055[Abstract/Free Full Text]
27. Tsien, R., and Pozzan, T. (1989) Methods Enzymol. 172, 230-262[Medline] [Order article via Infotrieve]
28. Thrower, E., Lea, E., and Dawson, A. (1998) Biochem. J. 330, 559-564
29. Michikawa, T., Hirota, J., Kawano, S., Hiraoka, M., Yamada, M., Furuichi, T., and Mikoshiba, K. (1999) Neuron 23, 799-808[CrossRef][Medline] [Order article via Infotrieve]
30. Bezprozvanny, I., Watras, J., and Ehrlich, B. E. (1991) Nature 351, 751-754[CrossRef][Medline] [Order article via Infotrieve]
31. Blondel, O., Bell, G. I., and Seino, S. (1995) Trends Neurosci. 18, 157-161[CrossRef][Medline] [Order article via Infotrieve]
32. Winkler, H., and Westhead, E. (1980) Neuroscience 5, 1803-1823[CrossRef][Medline] [Order article via Infotrieve]
33. Yoo, S. H., and Albanesi, J. P. (1991) J. Biol. Chem. 266, 7740-7745[Abstract/Free Full Text]
34. Bulenda, D., and Gratzl, M. (1985) Biochemistry 24, 7760-7765[CrossRef][Medline] [Order article via Infotrieve]
35. Roskams, T., van den Oord, J. J., De, Vos, R., and Desmet, V. J. (1990) Am. J. Pathol. 137, 1019-1025[Abstract]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
L. E. Wagner II, S. K. Joseph, and D. I. Yule
Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation
J. Physiol., August 1, 2008; 586(15): 3577 - 3596.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev, April 1, 2007; 87(2): 593 - 658.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
C.-u. Choe and B. E. Ehrlich
The Inositol 1,4,5-Trisphosphate Receptor (IP3R) and Its Regulators: Sometimes Good and Sometimes Bad Teamwork
Sci. Signal., November 28, 2006; 2006(363): re15 - re15.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. C. Thrower, A. P. E. Diaz de Villalvilla, T. R. Kolodecik, and F. S. Gorelick
Zymogen activation in a reconstituted pancreatic acinar cell system
Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G894 - G902.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. N. Jacob, C.-U. Choe, P. Uhlen, B. DeGray, M. F. Yeckel, and B. E. Ehrlich
Signaling Microdomains Regulate Inositol 1,4,5-Trisphosphate-Mediated Intracellular Calcium Transients in Cultured Neurons
J. Neurosci., March 16, 2005; 25(11): 2853 - 2864.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-U. Choe, K. D. Harrison, W. Grant, and B. E. Ehrlich
Functional Coupling of Chromogranin with the Inositol 1,4,5-Trisphosphate Receptor Shapes Calcium Signaling
J. Biol. Chem., August 20, 2004; 279(34): 35551 - 35556.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Cai, C. Hisatsune, K. Nakamura, T. Nakamura, T. Inoue, and K. Mikoshiba
Activity-dependent Expression of Inositol 1,4,5-Trisphosphate Receptor Type 1 in Hippocampal Neurons
J. Biol. Chem., May 28, 2004; 279(22): 23691 - 23698.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. Thrower, C. U. Choe, S. H. So, S. H. Jeon, B. E. Ehrlich, and S. H. Yoo
A Functional Interaction between Chromogranin B and the Inositol 1,4,5-Trisphosphate Receptor/Ca2+ Channel
J. Biol. Chem., December 12, 2003; 278(50): 49699 - 49706.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Caroppo, M. Colella, A. Colasuonno, A. DeLuisi, L. Debellis, S. Curci, and A. M. Hofer
A Reassessment of the Effects of Luminal [Ca2+] on Inositol 1,4,5-Trisphosphate-induced Ca2+ Release from Internal Stores
J. Biol. Chem., October 10, 2003; 278(41): 39503 - 39508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ando, A. Mizutani, T. Matsu-ura, and K. Mikoshiba
IRBIT, a Novel Inositol 1,4,5-Trisphosphate (IP3) Receptor-binding Protein, Is Released from the IP3 Receptor upon IP3 Binding to the Receptor
J. Biol. Chem., March 14, 2003; 278(12): 10602 - 10612.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. W. Johenning, M. Zochowski, S. J. Conway, A. B. Holmes, P. Koulen, and B. E. Ehrlich
Distinct Intracellular Calcium Transients in Neurites and Somata Integrate Neuronal Signals
J. Neurosci., July 1, 2002; 22(13): 5344 - 5353.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/18/15801    most recent
M110139200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thrower, E. C.
Right arrow Articles by Ehrli